JAN 17, 2022 3:00 AM PST

High Fiber Diet Provides a Helpful Boost to Melanoma Treatment

WRITTEN BY: Katie Kokolus

Immune checkpoint inhibitors (ICIs) have become a promising new treatment for advanced cancers, including melanoma. Immunotherapies, including ICIs, target a patient’s immune system to increase its ability to fight cancer as opposed to directly attacking cancer cells like traditional cancer therapies such as chemotherapy and radiation. While the ability of ICIs to improve survival for cancer patients is often profound, they remain effective only on a subset of patients. Thus, researchers actively seek new strategies for increasing the population of patients who respond to ICIs. A new manuscript published late last month in Science has uncovered a potential method for boosting the efficacy of immunotherapy: a high fiber diet.  

Gut microbiota influences how well an individual will respond to ICI therapy. Diet and supplement use directly impact the composition of the bacteria present in the gut, but whether diet plays a role in ICI efficacy is not well understood. The researchers addressed the relationship between diet and ICI response in a large cohort of melanoma patients. They found that patients with a high dietary fiber intake exhibited significantly better overall survival.

The study profiled the microbiota of each patient and collected data on dietary habits and supplement use.  Assessment of diet was based on patient-reported data.  All patients in the study received ICI to treat melanoma. 

About 30% of the 128 patients reported sufficient dietary fiber intake.  The patients reporting insufficient dietary fiber intake demonstrated an average progression-free survival time of 13 months.  The patients reporting sufficient dietary fiber intake had not yet reached average progression-free survival at the time of publication.  Further analysis revealed that every 5-gram increase in daily dietary fiber intake corresponded with a 30% reduction in risk of melanoma progression.

The researchers utilized a mouse model of melanoma generated using M3 melanoma cells to mimic the findings in a pre-clinical model.  Tumor-bearing mice were treated with ICI while consuming a high- or low-fiber diet.  In line with the clinical analysis, mice receiving a high fiber diet and ICI had significantly delayed tumor growth. 

The study combined clinical and pre-clinical analyses to demonstrate a link between fiber intake and ICI response.  Collectively, the data support an essential role of dietary fiber that should be considered for patients receiving ICI therapy.  Further investigation is warranted to evaluate the full impact of fiber intake for cancer patients, particularly those receiving immunotherapy.  ICIs have revolutionized the treatment of several types of cancer including melanoma, but the number of patients who do not respond remains disappointing. This study presents a new strategy that could be used to increase the number of responders. 

 

Sources: Science, Biochem J, Science

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
JAN 25, 2022
Immunology
Lung Cancer Vaccine Goes on Trial
JAN 25, 2022
Lung Cancer Vaccine Goes on Trial
Vaccines have been a hot topic in the headlines—blueprints that train the immune system to target a disease-causin ...
FEB 25, 2022
Cancer
Does Exercise Help Prep Tumors for Surgery?
FEB 25, 2022
Does Exercise Help Prep Tumors for Surgery?
Esophageal cancer, also known as cancer of the food pipe, gullet cancer, or oesophageal cancer, develops in the tube tha ...
MAR 14, 2022
Cancer
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
MAR 14, 2022
Expanded Approval for the PD-1 Blocking Immunotherapy Opdivo
Over the past decade, immunotherapy drugs known as immune checkpoint inhibitors have emerged as a promising an ...
APR 04, 2022
Cancer
Sweeteners Linked to Increased Cancer Risk
APR 04, 2022
Sweeteners Linked to Increased Cancer Risk
The World Health Organization (WHO) recommends we limit sugar consumption to less than 10% of daily energy intake. ...
MAY 01, 2022
Health & Medicine
Predicting Radiotherapy Resistance in Brain Metastases
MAY 01, 2022
Predicting Radiotherapy Resistance in Brain Metastases
Radiotherapy for brain metastasis can later cause neurocognitive decline. Sometimes this is a tradeoff when fightin ...
Loading Comments...